Cited 0 times in
Serum erythropoietin levels after living-donor renal allografts.
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, HY | - |
dc.contributor.author | Kim, HS | - |
dc.contributor.author | Kang, SW | - |
dc.contributor.author | Kang, DH | - |
dc.contributor.author | Yoo, HM | - |
dc.contributor.author | Choi, KH | - |
dc.contributor.author | Han, DS | - |
dc.contributor.author | Kim, YS | - |
dc.contributor.author | Park, KI | - |
dc.date.accessioned | 2011-09-05T01:58:21Z | - |
dc.date.available | 2011-09-05T01:58:21Z | - |
dc.date.issued | 1994 | - |
dc.identifier.issn | 0041-1345 | - |
dc.identifier.uri | http://repository.ajou.ac.kr/handle/201003/4013 | - |
dc.language.iso | en | - |
dc.subject.MESH | Adult | - |
dc.subject.MESH | Creatinine | - |
dc.subject.MESH | Cyclosporine | - |
dc.subject.MESH | Erythropoietin | - |
dc.subject.MESH | Female | - |
dc.subject.MESH | Hemoglobins | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Kidney Transplantation | - |
dc.subject.MESH | Male | - |
dc.subject.MESH | Postoperative Period | - |
dc.subject.MESH | Prednisone | - |
dc.subject.MESH | Radioimmunoassay | - |
dc.subject.MESH | Renal Insufficiency | - |
dc.subject.MESH | Reticulocyte Count | - |
dc.subject.MESH | Time Factors | - |
dc.subject.MESH | Tissue Donors | - |
dc.subject.MESH | Transplantation, Homologous | - |
dc.title | Serum erythropoietin levels after living-donor renal allografts. | - |
dc.type | Article | - |
dc.identifier.pmid | 8066705 | - |
dc.contributor.affiliatedAuthor | 김, 흥수 | - |
dc.type.local | Journal Papers | - |
dc.citation.title | Transplantation proceedings | - |
dc.citation.volume | 26 | - |
dc.citation.number | 4 | - |
dc.citation.date | 1994 | - |
dc.citation.startPage | 2151 | - |
dc.citation.endPage | 2153 | - |
dc.identifier.bibliographicCitation | Transplantation proceedings, 26(4). : 2151-2153, 1994 | - |
dc.identifier.eissn | 1873-2623 | - |
dc.relation.journalid | J000411345 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.